bipolar disorder

Specific Types of Genes and Mutations

  • Types of Mutated Genes:

    • Genes that regulate carcinoid signaling, monomies, and mitochondrial functions are implicated in bipolar disorder.

    • These mutations contribute to the likelihood of developing bipolar disease rather than directly causing it.

    • Suggested that these genetic pathways mediate the pathology associated with bipolar disorder.

Pathologies in Bipolar Disease

  • Brain Symmetry Modification:

    • Recent studies indicate modifications in the brain’s symmetry may be a factor in bipolar disorder.

    • Ongoing research aims to deepen understanding of these mechanisms.

  • Dopamine Neurotransmission Changes:

    • Hypothesis suggests changes in dopamine neurotransmission might play a role in bipolar disorder.

    • Dopamine Functions:

    • Key neurotransmitter involved in the brain's reward system.

    • Influences various neural pathways.

    • Imbalance in dopamine circuits:

    • Some dopamine-using circuits are upregulated, while others are downregulated.

    • Associated with receptor inhibition and potentiation.


Specific Types of Genes and Mutations
  • Types of Mutated Genes:

    • Genes that regulate calcium signaling (such as CACNA1CCACNA1C), cell signaling, and mitochondrial functions are heavily implicated in bipolar disorder.

    • These mutations contribute to a "polygenic risk," meaning many small genetic variations combine to increase susceptibility rather than a single gene causing the disorder.

    • Mutations in mitochondrial DNA can lead to cellular energy deficits and increased oxidative stress in neurons, affecting overall brain health.

    • Suggested that these genetic pathways mediate the pathology associated with bipolar disorder by altering neurotransmitter release and neuronal excitability.

Pathologies in Bipolar Disease
  • Brain Symmetry and Structural Modifications:

    • Recent studies indicate modifications in the brain’s symmetry may be a factor, specifically in the prefrontal cortex (PFCPFC) and temporal regions.

    • Neuroimaging often shows reduced gray matter volume in areas like the anterior cingulate cortex (ACCACC) and the hippocampus, which govern emotion and memory.

    • Ongoing research aims to deepen understanding of how these structural changes correlate with the frequency of mood cycles.

  • Dopamine Neurotransmission Changes:

    • The Dopamine Hypothesis: Mania is frequently linked to high dopamine activity or oversensitive receptors, whereas depression is linked to low dopamine states.

    • Dopamine Functions:

    • Key neurotransmitter involved in the brain's reward system, motivation, and motor coordination.

    • Influences various neural pathways including the mesolimbic and mesocortical systems.

    • Imbalance in Dopamine Circuits:

    • Some dopamine-using circuits, particularly in the reward centers (ventral striatum), are upregulated during manic episodes, leading to impulsivity.

    • Other circuits may be downregulated during depressive episodes, contributing to a lack of motivation (anhedonia).

    • Associated with receptor inhibition, potentiation, and changes in synapse density.

  • Neurochemical and Biological Factors:

    • Neuroplasticity: Reduced levels of Brain-Derived Neurotrophic Factor (BDNFBDNF) are observed during mood episodes, which may impair the brain's ability to maintain healthy neuronal connections.

    • Circadian Rhythms: Dysregulation of "clock" genes often leads to the sleep-wake cycle disturbances that are a hallmark of the disorder.